Invesco’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,911,638
Closed -$259M 3760
2017
Q1
$259M Buy
2,911,638
+950,647
+48% +$78.2M 0.09% 254
2016
Q4
$139M Buy
1,960,991
+196,062
+11% +$14.6M 0.05% 404
2016
Q3
$139M Buy
1,764,929
+31,550
+2% +$2.69M 0.05% 402
2016
Q2
$157M Sell
1,733,379
-108,952
-6% -$9.23M 0.06% 356
2016
Q1
$157M Sell
1,842,331
-502,427
-21% -$37.4M 0.06% 352
2015
Q4
$185M Buy
2,344,758
+382,123
+19% +$30.1M 0.07% 302
2015
Q3
$138M Buy
1,962,635
+620,443
+46% +$51M 0.06% 372
2015
Q2
$121M Sell
1,342,192
-369,558
-22% -$35.6M 0.05% 445
2015
Q1
$172M Sell
1,711,750
-441,006
-20% -$44.5M 0.07% 351
2014
Q4
$216M Buy
2,152,756
+155,799
+8% +$15.5M 0.08% 279
2014
Q3
$192M Buy
1,996,957
+221,006
+12% +$20.9M 0.08% 298
2014
Q2
$165M Sell
1,775,951
-262,034
-13% -$22.9M 0.07% 350
2014
Q1
$169M Buy
2,037,985
+700,020
+52% +$56.7M 0.07% 335
2013
Q4
$112M Buy
1,337,965
+121,156
+10% +$9.87M 0.04% 473
2013
Q3
$90.4M Buy
1,216,809
+223,080
+22% +$16.7M 0.04% 517
2013
Q2
$78.7M Buy
+993,729
New +$79.7M 0.04% 523

Other funds holding MJN

Invesco's MJN Position: Q2 2017 in Review

Invesco sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 2,911,638 shares — an estimated $259M sold.

Invesco first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $259M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Invesco reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Invesco sold 2,911,638 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $259M.
  • Invesco first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Invesco's Mead Johnson Nutrition Company position peaked at $259M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Invesco's 13F filing for Q2 2017, filed 14 Aug 2017.